SCHEMBL571487

SCHEMBL571487

CCCCCCCCCCCCCCCCCCCCCCC(=CC(=O)O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 4/20 0.52
PTPN1 P18031 3/20 0.52
FABP4 P15090 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 2/20 0.52
HSD17B10 Q99714 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
PDE4A P27815 1/20 0.52
KMT2A Q03164 1/20 0.52
PDE3A Q14432 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172213 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11537088 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7149850 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL891122 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL877868 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5083590 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3629983 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11072779 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5160144 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL1400163 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1368057-B1 METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN TORREY PINES INST (US) 2009-08-26 EP claimed
EP-1281384-B1 Mascara comprising solid particles OREAL (FR) 2009-03-18 EP claimed
EP-1071411-B1 TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION TORREY PINES INST (US) 2007-03-14 EP claimed
US-7029662-B2 Wax-in-water dispersion in a cosmetically acceptable medium, a nonvolatile fraction of a polymer that can adhere to eyelash and wax particles of given physical properties; can give good curling of eyelashes L'OREAL (FR) 2006-04-18 US claimed
EP-1071411-A4 TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION TORREY PINES INST (US) 2004-12-08 EP claimed
EP-1368057-A2 METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN Lancell, Llc (US) 2003-12-10 EP claimed
US-20030059388-A1 Wax-in-water dispersion in a cosmetically acceptable medium, a nonvolatile fraction of a polymer that can adhere to eyelash and wax particles of given physical properties; can give good curling of eyelashes L'OREAL S.A. (FR) 2003-03-27 US claimed
WO-2002074332-A2 METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN LANCELL, LLC (US) 2002-09-26 WO claimed
US-20010024649-A1 Method to enhance the immunogenicity of an antigen TORREY PINES INSTITUTE FOR MOLECULAR STUDIES 2001-09-27 US claimed
US-6210672-B1 TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. TORREY PINES INSTITUTE FOR MOLECULAR STUDIES 2001-04-03 US claimed
EP-1071411-A1 TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 2001-01-31 EP claimed
WO-1999053912-A1 TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) 1999-10-28 WO claimed
EP-0155105-B1 DIALKYL FUMARATE-VINYL ACETATE COPOLYMERS USEFUL AS DEWAXING AIDS EXXON RESEARCH AND ENGINEERING COMPANY (US) 1988-06-15 EP claimed
EP-0107917-B1 SOLVENT DEWAXING WAXY HYDROCARBON OIL DISTILLATES USING A COMBINATION POLY DI-ALKYL FUMARATE-VINYL ACETATE COPOLYMER HAVING PENDENT CARBON SIDE CHAIN LENGTH OF PREDOMINANTLY C 22 AND POLYALKYL (METH-)ACRYLATE POLYMER DEWAXING AID EXXON RESEARCH AND ENGINEERING COMPANY (US) 1986-11-26 EP claimed
EP-2218328-B1 Oil-based agrochemical compositions with increased viscosity COGNIS IP MAN GMBH (DE) 2016-04-13 EP disclosed
US-8580287-B2 Oil-based agrochemical compositions with increased viscosity COGNIS IP MANAGEMENT GMBH (DE) 2013-11-12 US disclosed
WO-2012016578-A1 THICKENING AGENTS FOR COSMETIC OIL PHASES COGNIS IP MANAGEMENT GMBH (DE) 2012-02-09 WO disclosed
EP-0107917-B1 SOLVENT DEWAXING WAXY HYDROCARBON OIL DISTILLATES USING A COMBINATION POLY DI-ALKYL FUMARATE-VINYL ACETATE COPOLYMER HAVING PENDENT CARBON SIDE CHAIN LENGTH OF PREDOMINANTLY C 22 AND POLYALKYL (METH-)ACRYLATE POLYMER DEWAXING AID EXXON RESEARCH AND ENGINEERING COMPANY (US) 1986-11-26 EP disclosed
EP-0107917-A1 Solvent dewaxing waxy hydrocarbon oil distillates using a combination poly di-alkyl fumarate-vinyl acetate copolymer having pendent carbon side chain length of predominantly C 22 and polyalkyl (meth-)acrylate polymer dewaxing aid EXXON RESEARCH AND ENGINEERING COMPANY (US) 1984-05-09 EP disclosed
US-4406771-A Solvent dewaxing waxy hydrocarbon oil distillates using a combination poly di-alkyl fumarate-vinyl acetate copolymer having pendent carbon side chain length of predominantly C22 and polyalkyl(meth-)acrylate polymer dewaxing aid EXXON RESEARCH AND ENGINEERING CO. (US) 1983-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010024649-A1 Method to enhance the immunogenicity of an antigen CD69, CD74, LY96 GPR84 1226/4885PPARG 4130/4885PPARD 4538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.